Immunomodulatory Agents in Follicular Lymphoma. - Université de Lille Accéder directement au contenu
Article Dans Une Revue Hematology/Oncology Clinics of North America Année : 2020

Immunomodulatory Agents in Follicular Lymphoma.

Résumé

• Immunomodulatory agents are now part of modern follicular lymphoma therapeutic management. • They offer a chemo-free strategy that provides a clinical benefit even for high-risk disease. • These strategies target tumor cells both directly and through microenvironment modifications. • We are still lacking biomarkers predicting efficacy of immunomodulatory agents.
Fichier non déposé

Dates et versions

hal-04197383 , version 1 (06-09-2023)

Identifiants

Citer

Loïc Ysebaert, Franck Morschhauser. Immunomodulatory Agents in Follicular Lymphoma.. Hematology/Oncology Clinics of North America, 2020, Hematology/Oncology Clinics of North America, 34 (4), pp.715-726. ⟨10.1016/j.hoc.2020.02.007⟩. ⟨hal-04197383⟩

Collections

UNIV-LILLE
7 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More